David B. Weiner, Director at INOVIO PHARMACEUTICALS, INC. (INO), sold 3,045 shares at $6.62 ($20K) on 2021-05-17, disclosed to the SEC on 2021-05-17.
Scheduled sale ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INO | SELL | 2022-08-11 | $32K | — | Filing → |
| INO | SELL | 2022-05-17 | $18K | — | Filing → |
| INO | SELL | 2022-03-14 | $13K | — | Filing → |